Physician Wealth Advisors’s Lemonade LMND Stock Holding History

Physician Wealth Advisors’s Portfolio LMND Stock Details LMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$391	Buy	+6	New	+$351	﹤0.01%	2247

Other funds holding LMND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Physician Wealth Advisors's LMND Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Lemonade (LMND) in Q2 2026: 6 shares worth $391. The stake represents ﹤0.01% of the portfolio and ranks #2247 among its holdings.

336 funds tracked by Wall St. Rank hold LMND as of Q2 2026.

Physician Wealth Advisors held 6 shares of Lemonade worth $391 as of Q2 2026.
Lemonade was a new Physician Wealth Advisors position in Q2 2026.
Lemonade made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2247 holding.
336 funds tracked by Wall St. Rank held Lemonade as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.